CRISPR-carrying nanoparticles edit the genome
New delivery system deletes disease-causing genes and reduces cholesterol...
List view / Grid view
News
Next-generation optogenetic molecules control single neurons
Focused laser beam could help scientists map connections among neurons that underlie behaviour...
Synthetic T-cells engineered to combat cancer
Researchers have engineered T-cells in the laboratory to combat tumours...
CRISPR-dCas9 reveals surprising insight into breast cancer development
Changing the epigenetic code of a single gene is enough to cause a healthy breast cell to become abnormal...
VEGF found to prolong survival of stem cells
A team of researchers have developed a new technology, which is promising to understand and treat ischemic diseases...
Exclusive speaker interview with Professor Nagy Habib – MiNA Therapeutics/Imperial College London
SMi are delighted to have, Nagy Habib, Head of HPB Surgery, Imperial College London and Co-Founder, MiNA Therapeutics, as the Keynote Address for day 1 at RNA Therapeutics 2018!
Ancient antiviral response could help treat cancer
By stimulating a patient’s immune system, a drug already in use to treat a blood disorder can prevent the growth of a variety of solid tumours...
Scientists identify new treatment for Activated PI3-kinase Delta Syndrome
Scientists have identified a new treatment approach for patients with a rare inherited immune disorder...
Scientists create “tracking” nanoagents to illuminate very small diseased tissues
Polymer nanoagents that can ‘light up’ tiny areas of diseased tissues that conventional methods fail to detect, have been created by a research team led by NTU Singapore.
DNA analysis incorporated into antenatal screening to test for chromosome disorders
Scientists have shown that it is possible to incorporate DNA analysis into antenatal screening for three serious chromosome disorders including Down's syndrome...
Researchers produce the first draft cell atlas of the small intestine
By surveying gene expression, researchers have created a reference atlas for understanding the biology of inflammatory bowel disease and food allergies, among other conditions...
FDG PET shows tumour DNA levels in blood are linked to NSCLC
Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer...
Selective PDE4D inhibitor shows potential to treat Fragile X syndrome
Preclinical research suggests the potential utility of BPN14770, as a prospective treatment for Alzheimer's disease...
LXB4 lipid protect neurons against glaucoma
Researchers have identified a new neuroprotective factor that has the potential to help people suffering from glaucoma...
Charles River Laboratories presents newly expanded capabilities at Neuroscience 2017
Charles River Laboratories International, Inc. announced that its team of neuroscience drug discovery experts is presenting 27 scientific posters, both independently and collaboratively with clients, at Neuroscience 2017, the 47th annual meeting of the Society for Neuroscience (SfN).